arrow
F

Frances A. Collichio

university of north carolina school of medicine
H指数:33
被引数:9,561

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anatomic Location Predicts Response Rates: Real World Outcomes With Over 1100 Cycles of Talimogene Laherparepvec Description

Dougherty, K.E.; Peery, G.B.; Agala, C.B.; Pham, V.P.; Gwynn, M.E.; Meyers, M.O.; Stitzenberg, K.B.; Sorah, J.D.; Long, P.K.; Jones, C.P.; et al. 解剖位置预测反应率:超过1,100个周期的Talimogene Laherparepvec(TVEC)的实际世界结果:一项前瞻性维护数据库的回顾性研究。Ann. Surg. 2025; ahead of print. [Google Scholar] [CrossRef]

2025-12-012
PRE
Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma
2024-03-220
PRE
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy
2023-12-016
PRE
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
2023-08-1743
OA
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
2023-05-199
OA
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma
2023-04-265
OA
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma
2022-01-058
OAAI
ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience
2021-11-241
PRE
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
2021-10-1420
PRE
A randomized, controlled, open-label, phase II study of cemiplimab as a single agent and in combination with RP1 in patients with advanced cutaneous squamous cell carcinoma [CERPASS]
2021-09-011
OA
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
2021-01-2119
OAAI
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
2019-01-0416
OAAI